<html>
<head>PUBMED IDs for MADH2</head>
<body bgcolor='#C5F0F2'><h1>MADH2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9503010/'>Characterization of the MADH2/Smad2 gene, a human Mad homolog responsible for the transforming growth factor-beta and activin signal transduction pathway.</a> March 21  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10719364/'>Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.</a> March 17  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11304690/'>Analysis of human meningiomas for aberrations of the MADH2, MADH4, APM-1 and DCC tumor suppressor genes on the long arm of chromosome 18.</a> April 17  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/14985451/'>Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts.</a> February 27  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15235134/'>Genome-wide search for loss of heterozygosity in Chinese patients with sporadic colorectal cancer.</a> July 6  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15235132/'>Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese.</a> July 6  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15235131/'>Expression of MUC5AC and MUC6 in invasive ductal carcinoma of the pancreas and relationship with prognosis.</a> July 6  2004<br></body></html>
